2015-2027 Global Immunosuppressant Drugs Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

April 2020 | 140 pages | ID: 22B5D2F6E78FEN
Maia Research

Abstracts

The worldwide market for Immunosuppressant Drugs is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020.

The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.

Major Companies Covered
Veloxis Pharmaceuticals
GSK
AbbVie
Novartis
Bristol-Myers Squibb
Allergan
Roche
Pfizer
Sanofi
Astellas Pharma

Major Types Covered
Calcineurin Inhibitors
MTOR Inhibitors
Anti-proliferative Agents
Steroids
Antibodies

Major Applications Covered
Kidney
Bone Marrow
Others

Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027

Contents

1 INTRODUCTION

1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
  1.3.1 Market Segment by Type, Application and Marketing Channel
  1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders

2 KEY FINDINGS OF THE STUDY

3 MARKET DYNAMICS

3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Immunosuppressant Drugs Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Immunosuppressant Drugs Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis

4 VALUE CHAIN OF THE IMMUNOSUPPRESSANT DRUGS MARKET

4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)

5 GLOBAL IMMUNOSUPPRESSANT DRUGS MARKET-SEGMENTATION BY TYPE

5.1 Calcineurin Inhibitors
5.2 MTOR Inhibitors
5.3 Anti-proliferative Agents
5.4 Steroids
5.5 Antibodies

6 GLOBAL IMMUNOSUPPRESSANT DRUGS MARKET-SEGMENTATION BY APPLICATION

6.1 Kidney
6.2 Bone Marrow
6.3 Others

7 GLOBAL IMMUNOSUPPRESSANT DRUGS MARKET-SEGMENTATION BY MARKETING CHANNEL

7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel

8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES

8.1 Veloxis Pharmaceuticals
  8.1.1 Veloxis Pharmaceuticals Profile
  8.1.2 Veloxis Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
  8.1.3 Veloxis Pharmaceuticals Product/Solution Launches and Enhancements Analysis
  8.1.4 Veloxis Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.2 GSK
  8.2.1 GSK Profile
  8.2.2 GSK Sales, Growth Rate and Global Market Share from 2015-2020
  8.2.3 GSK Product/Solution Launches and Enhancements Analysis
  8.2.4 GSK Business Overview/Recent Development/Acquisitions
8.3 AbbVie
  8.3.1 AbbVie Profile
  8.3.2 AbbVie Sales, Growth Rate and Global Market Share from 2015-2020
  8.3.3 AbbVie Product/Solution Launches and Enhancements Analysis
  8.3.4 AbbVie Business Overview/Recent Development/Acquisitions
8.4 Novartis
  8.4.1 Novartis Profile
  8.4.2 Novartis Sales, Growth Rate and Global Market Share from 2015-2020
  8.4.3 Novartis Product/Solution Launches and Enhancements Analysis
  8.4.4 Novartis Business Overview/Recent Development/Acquisitions
8.5 Bristol-Myers Squibb
  8.5.1 Bristol-Myers Squibb Profile
  8.5.2 Bristol-Myers Squibb Sales, Growth Rate and Global Market Share from 2015-2020
  8.5.3 Bristol-Myers Squibb Product/Solution Launches and Enhancements Analysis
  8.5.4 Bristol-Myers Squibb Business Overview/Recent Development/Acquisitions
8.6 Allergan
  8.6.1 Allergan Profile
  8.6.2 Allergan Sales, Growth Rate and Global Market Share from 2015-2020
  8.6.3 Allergan Product/Solution Launches and Enhancements Analysis
  8.6.4 Allergan Business Overview/Recent Development/Acquisitions
8.7 Roche
  8.7.1 Roche Profile
  8.7.2 Roche Sales, Growth Rate and Global Market Share from 2015-2020
  8.7.3 Roche Product/Solution Launches and Enhancements Analysis
  8.7.4 Roche Business Overview/Recent Development/Acquisitions
8.8 Pfizer
  8.8.1 Pfizer Profile
  8.8.2 Pfizer Sales, Growth Rate and Global Market Share from 2015-2020
  8.8.3 Pfizer Product/Solution Launches and Enhancements Analysis
  8.8.4 Pfizer Business Overview/Recent Development/Acquisitions
8.9 Sanofi
  8.9.1 Sanofi Profile
  8.9.2 Sanofi Sales, Growth Rate and Global Market Share from 2015-2020
  8.9.3 Sanofi Product/Solution Launches and Enhancements Analysis
  8.9.4 Sanofi Business Overview/Recent Development/Acquisitions
8.10 Astellas Pharma
  8.10.1 Astellas Pharma Profile
  8.10.2 Astellas Pharma Sales, Growth Rate and Global Market Share from 2015-2020
  8.10.3 Astellas Pharma Product/Solution Launches and Enhancements Analysis
  8.10.4 Astellas Pharma Business Overview/Recent Development/Acquisitions

9 GLOBAL IMMUNOSUPPRESSANT DRUGS MARKET-SEGMENTATION BY GEOGRAPHY

10 NORTH AMERICA

10.1 North America Immunosuppressant Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Immunosuppressant Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Immunosuppressant Drugs Production Analysis from 2015-2020
10.4 North America Immunosuppressant Drugs Consumption Analysis from 2015-2020
10.5 North America Immunosuppressant Drugs Import and Export from 2015-2020
10.6 North America Immunosuppressant Drugs Value, Production and Market Share by Type (2015-2020)
10.7 North America Immunosuppressant Drugs Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Immunosuppressant Drugs by Country (United States, Canada)
  10.8.1 North America Immunosuppressant Drugs Sales by Country (2015-2020)
  10.8.2 North America Immunosuppressant Drugs Consumption Value by Country (2015-2020)
10.9 North America Immunosuppressant Drugs Market PEST Analysis

11 EUROPE

11.1 Europe Immunosuppressant Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Immunosuppressant Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Immunosuppressant Drugs Production Analysis from 2015-2020
11.4 Europe Immunosuppressant Drugs Consumption Analysis from 2015-2020
11.5 Europe Immunosuppressant Drugs Import and Export from 2015-2020
11.6 Europe Immunosuppressant Drugs Value, Production and Market Share by Type (2015-2020)
11.7 Europe Immunosuppressant Drugs Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Immunosuppressant Drugs by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
  11.8.1 Europe Immunosuppressant Drugs Sales by Country (2015-2020)
  11.8.2 Europe Immunosuppressant Drugs Consumption Value by Country (2015-2020)
11.9 Europe Immunosuppressant Drugs Market PEST Analysis

12 ASIA-PACIFIC

12.1 Asia-Pacific Immunosuppressant Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Immunosuppressant Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Immunosuppressant Drugs Production Analysis from 2015-2020
12.4 Asia-Pacific Immunosuppressant Drugs Consumption Analysis from 2015-2020
12.5 Asia-Pacific Immunosuppressant Drugs Import and Export from 2015-2020
12.6 Asia-Pacific Immunosuppressant Drugs Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Immunosuppressant Drugs Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Immunosuppressant Drugs by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
  12.8.1 Asia-Pacific Immunosuppressant Drugs Sales by Country (2015-2020)
  12.8.2 Asia-Pacific Immunosuppressant Drugs Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Immunosuppressant Drugs Market PEST Analysis

13 LATIN AMERICA

13.1 Latin America Immunosuppressant Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Immunosuppressant Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Immunosuppressant Drugs Production Analysis from 2015-2020
13.4 Latin America Immunosuppressant Drugs Consumption Analysis from 2015-2020
13.5 Latin America Immunosuppressant Drugs Import and Export from 2015-2020
13.6 Latin America Immunosuppressant Drugs Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Immunosuppressant Drugs Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Immunosuppressant Drugs by Country (Brazil, Mexico, Argentina, Columbia, Chile)
  13.8.1 Latin America Immunosuppressant Drugs Sales by Country (2015-2020)
  13.8.2 Latin America Immunosuppressant Drugs Consumption Value by Country (2015-2020)
13.9 Latin America Immunosuppressant Drugs Market PEST Analysis

14 MIDDLE EAST & AFRICA

14.1 Middle East & Africa Immunosuppressant Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Immunosuppressant Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Immunosuppressant Drugs Production Analysis from 2015-2020
14.4 Middle East & Africa Immunosuppressant Drugs Consumption Analysis from 2015-2020
14.5 Middle East & Africa Immunosuppressant Drugs Import and Export from 2015-2020
14.6 Middle East & Africa Immunosuppressant Drugs Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Immunosuppressant Drugs Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Immunosuppressant Drugs by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
  14.8.1 Middle East & Africa Immunosuppressant Drugs Sales by Country (2015-2020)
  14.8.2 Middle East & Africa Immunosuppressant Drugs Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Immunosuppressant Drugs Market PEST Analysis

15 FUTURE FORECAST OF THE GLOBAL IMMUNOSUPPRESSANT DRUGS MARKET FROM 2020-2027

15.1 Future Forecast of the Global Immunosuppressant Drugs Market from 2020-2027 Segment by Region
15.2 Global Immunosuppressant Drugs Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Immunosuppressant Drugs Consumption and Growth Rate Forecast by Application (2020-2027)

16 APPENDIX

16.1 Methodology
16.2 Research Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Global Immunosuppressant Drugs Market Value ($) and Growth Rate of Immunosuppressant Drugs from 2015-2027
Global Immunosuppressant Drugs Production and Growth Rate Segment by Product Type from 2015-2027
Global Immunosuppressant Drugs Consumption and Growth Rate Segment by Application from 2015-2027
Figure Immunosuppressant Drugs Picture
Table Product Specifications of Immunosuppressant Drugs
Table Driving Factors for this Market
Table Industry News of Immunosuppressant Drugs Market
Figure Value Chain Status of Immunosuppressant Drugs
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Immunosuppressant Drugs Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Immunosuppressant Drugs Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Calcineurin Inhibitors of Immunosuppressant Drugs
Figure MTOR Inhibitors of Immunosuppressant Drugs
Figure Anti-proliferative Agents of Immunosuppressant Drugs
Figure Steroids of Immunosuppressant Drugs
Figure Antibodies of Immunosuppressant Drugs
Table Global Immunosuppressant Drugs Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Immunosuppressant Drugs Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Kidney of Immunosuppressant Drugs
Figure Bone Marrow of Immunosuppressant Drugs
Figure Others of Immunosuppressant Drugs
Table Global Immunosuppressant Drugs Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Immunosuppressant Drugs Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Immunosuppressant Drugs
Figure Online Channel of Immunosuppressant Drugs
Table Veloxis Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure Veloxis Pharmaceuticals Sales and Growth Rate from 2015-2020
Figure Veloxis Pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table Veloxis Pharmaceuticals Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table GSK Profile (Company Name, Plants Distribution, Sales Region)
Figure GSK Sales and Growth Rate from 2015-2020
Figure GSK Revenue ($) and Global Market Share from 2015-2020
Table GSK Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table AbbVie Profile (Company Name, Plants Distribution, Sales Region)
Figure AbbVie Sales and Growth Rate from 2015-2020
Figure AbbVie Revenue ($) and Global Market Share from 2015-2020
Table AbbVie Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Novartis Profile (Company Name, Plants Distribution, Sales Region)
Figure Novartis Sales and Growth Rate from 2015-2020
Figure Novartis Revenue ($) and Global Market Share from 2015-2020
Table Novartis Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Bristol-Myers Squibb Profile (Company Name, Plants Distribution, Sales Region)
Figure Bristol-Myers Squibb Sales and Growth Rate from 2015-2020
Figure Bristol-Myers Squibb Revenue ($) and Global Market Share from 2015-2020
Table Bristol-Myers Squibb Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Allergan Profile (Company Name, Plants Distribution, Sales Region)
Figure Allergan Sales and Growth Rate from 2015-2020
Figure Allergan Revenue ($) and Global Market Share from 2015-2020
Table Allergan Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Roche Profile (Company Name, Plants Distribution, Sales Region)
Figure Roche Sales and Growth Rate from 2015-2020
Figure Roche Revenue ($) and Global Market Share from 2015-2020
Table Roche Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Pfizer Profile (Company Name, Plants Distribution, Sales Region)
Figure Pfizer Sales and Growth Rate from 2015-2020
Figure Pfizer Revenue ($) and Global Market Share from 2015-2020
Table Pfizer Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Sanofi Profile (Company Name, Plants Distribution, Sales Region)
Figure Sanofi Sales and Growth Rate from 2015-2020
Figure Sanofi Revenue ($) and Global Market Share from 2015-2020
Table Sanofi Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Astellas Pharma Profile (Company Name, Plants Distribution, Sales Region)
Figure Astellas Pharma Sales and Growth Rate from 2015-2020
Figure Astellas Pharma Revenue ($) and Global Market Share from 2015-2020
Table Astellas Pharma Immunosuppressant Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Immunosuppressant Drugs Production Value ($) by Region from 2015-2020
Table Global Immunosuppressant Drugs Production Value Share by Region from 2015-2020
Table Global Immunosuppressant Drugs Production by Region from 2015-2020
Table Global Immunosuppressant Drugs Consumption Value ($) by Region from 2015-2020
Table Global Immunosuppressant Drugs Consumption by Region from 2015-2020
Table North America Immunosuppressant Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Immunosuppressant Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Immunosuppressant Drugs Import and Export from 2015-2020
Table North America Immunosuppressant Drugs Value ($) by Type (2015-2020)
Table North America Immunosuppressant Drugs Production by Type (2015-2020)
Table North America Immunosuppressant Drugs Consumption by Application (2015-2020)
Table North America Immunosuppressant Drugs Consumption by Country (2015-2020)
Table North America Immunosuppressant Drugs Consumption Value ($) by Country (2015-2020)
Figure North America Immunosuppressant Drugs Market PEST Analysis
Table Europe Immunosuppressant Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Immunosuppressant Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Immunosuppressant Drugs Import and Export from 2015-2020
Table Europe Immunosuppressant Drugs Value ($) by Type (2015-2020)
Table Europe Immunosuppressant Drugs Production by Type (2015-2020)
Table Europe Immunosuppressant Drugs Consumption by Application (2015-2020)
Table Europe Immunosuppressant Drugs Consumption by Country (2015-2020)
Table Europe Immunosuppressant Drugs Consumption Value ($) by Country (2015-2020)
Figure Europe Immunosuppressant Drugs Market PEST Analysis
Table Asia-Pacific Immunosuppressant Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Immunosuppressant Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Immunosuppressant Drugs Import and Export from 2015-2020
Table Asia-Pacific Immunosuppressant Drugs Value ($) by Type (2015-2020)
Table Asia-Pacific Immunosuppressant Drugs Production by Type (2015-2020)
Table Asia-Pacific Immunosuppressant Drugs Consumption by Application (2015-2020)
Table Asia-Pacific Immunosuppressant Drugs Consumption by Country (2015-2020)
Table Asia-Pacific Immunosuppressant Drugs Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Immunosuppressant Drugs Market PEST Analysis
Table Latin America Immunosuppressant Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Immunosuppressant Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Immunosuppressant Drugs Import and Export from 2015-2020
Table Latin America Immunosuppressant Drugs Value ($) by Type (2015-2020)
Table Latin America Immunosuppressant Drugs Production by Type (2015-2020)
Table Latin America Immunosuppressant Drugs Consumption by Application (2015-2020)
Table Latin America Immunosuppressant Drugs Consumption by Country (2015-2020)
Table Latin America Immunosuppressant Drugs Consumption Value ($) by Country (2015-2020)
Figure Latin America Immunosuppressant Drugs Market PEST Analysis
Table Middle East & Africa Immunosuppressant Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Immunosuppressant Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Immunosuppressant Drugs Import and Export from 2015-2020
Table Middle East & Africa Immunosuppressant Drugs Value ($) by Type (2015-2020)
Table Middle East & Africa Immunosuppressant Drugs Production by Type (2015-2020)
Table Middle East & Africa Immunosuppressant Drugs Consumption by Application (2015-2020)
Table Middle East & Africa Immunosuppressant Drugs Consumption by Country (2015-2020)
Table Middle East & Africa Immunosuppressant Drugs Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Immunosuppressant Drugs Market PEST Analysis
Table Global Immunosuppressant Drugs Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Immunosuppressant Drugs Production and Growth Rate Forecast by Region (2020-2027)
Table Global Immunosuppressant Drugs Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Immunosuppressant Drugs Production and Growth Rate Forecast by Type (2020-2027)
Table Global Immunosuppressant Drugs Consumption and Growth Rate Forecast by Application (2020-2027)